FR2292470A1 - Nouvelles compositions pour le traitement de l'hyperlipidemie - Google Patents

Nouvelles compositions pour le traitement de l'hyperlipidemie

Info

Publication number
FR2292470A1
FR2292470A1 FR7536295A FR7536295A FR2292470A1 FR 2292470 A1 FR2292470 A1 FR 2292470A1 FR 7536295 A FR7536295 A FR 7536295A FR 7536295 A FR7536295 A FR 7536295A FR 2292470 A1 FR2292470 A1 FR 2292470A1
Authority
FR
France
Prior art keywords
hyperlipidemia
treatment
new compositions
compositions
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7536295A
Other languages
English (en)
Other versions
FR2292470B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline LLC
Original Assignee
SmithKline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Corp filed Critical SmithKline Corp
Publication of FR2292470A1 publication Critical patent/FR2292470A1/fr
Application granted granted Critical
Publication of FR2292470B1 publication Critical patent/FR2292470B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
FR7536295A 1974-11-27 1975-11-27 Nouvelles compositions pour le traitement de l'hyperlipidemie Granted FR2292470A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/527,560 US3969508A (en) 1974-11-27 1974-11-27 Lowering the concentration of plasma triglycerides

Publications (2)

Publication Number Publication Date
FR2292470A1 true FR2292470A1 (fr) 1976-06-25
FR2292470B1 FR2292470B1 (fr) 1978-11-10

Family

ID=24101958

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7536295A Granted FR2292470A1 (fr) 1974-11-27 1975-11-27 Nouvelles compositions pour le traitement de l'hyperlipidemie

Country Status (10)

Country Link
US (1) US3969508A (fr)
AU (1) AU499316B2 (fr)
BE (1) BE835823A (fr)
DE (1) DE2553101A1 (fr)
FR (1) FR2292470A1 (fr)
GB (1) GB1535203A (fr)
IL (1) IL48518A (fr)
NL (1) NL7513877A (fr)
PH (2) PH11295A (fr)
ZA (1) ZA757439B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2387651A1 (fr) * 1977-04-22 1978-11-17 Ugine Kuhlmann Nouvelles compositions therapeutiques a action choleretique a base d'un derive de l'acide phenoxy acetique

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4089970A (en) * 1977-09-07 1978-05-16 Smithkline Corporation Method of inhibiting platelet aggregation
US4532135A (en) * 1981-02-09 1985-07-30 Edwards K David G Renoprotective treatments employing vasodilator compounds

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE757001A (fr) * 1969-10-10 1971-03-16 Cerpha Derives heterocycliques d'acides phenoxy acetique et leur preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB760114A (en) * 1953-06-19 1956-10-31 Chimie Atomistique Improvements in and relating to compositions for lowering the cholesterol level in the blood serum
US3402198A (en) * 1965-10-20 1968-09-17 William A. Bolhofer 2-(phenoxy), 2-(phenylthio) and 2-(anilino) substituted 2-alkylideneacetic acid derivatives
GB1228236A (fr) * 1968-05-20 1971-04-15

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE757001A (fr) * 1969-10-10 1971-03-16 Cerpha Derives heterocycliques d'acides phenoxy acetique et leur preparation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2387651A1 (fr) * 1977-04-22 1978-11-17 Ugine Kuhlmann Nouvelles compositions therapeutiques a action choleretique a base d'un derive de l'acide phenoxy acetique

Also Published As

Publication number Publication date
FR2292470B1 (fr) 1978-11-10
ZA757439B (en) 1976-11-24
NL7513877A (nl) 1976-05-31
DE2553101A1 (de) 1976-08-12
US3969508A (en) 1976-07-13
PH11295A (en) 1977-11-02
AU8689475A (en) 1977-06-02
IL48518A0 (en) 1976-01-30
PH12855A (en) 1979-09-12
BE835823A (fr) 1976-05-21
GB1535203A (en) 1978-12-13
IL48518A (en) 1978-08-31
AU499316B2 (en) 1979-04-12

Similar Documents

Publication Publication Date Title
BE824782A (fr) Compositions pour le traitement de gingivite
BE851328A (fr) Composition pour le traitement de l'hypercholesterolemie
BE822770A (fr) Composition pour le traitement de la diarrhee
FR2273509A1 (fr) Article pour le traitement des menstrues
FR2274365A1 (fr) Installation pour l'application de revetements par detonation
BE843359A (fr) Preparation pour le traitement de parodontose
BE829830A (fr) Composition pour traiter la schizophrenie
BE849416A (fr) Composition anti-moussage pour le traitement de denrees alimentaires
BE828555A (fr) Composition pour le traitement d'infections virales
FR2286238A1 (fr) Machine mobile pour le traitement des voies ferrees
BE812907A (fr) Compositions pour le traitement de la diarrhee
BE807080A (fr) Compositions pour le traitement de surfaces
BE826211A (fr) Compositions reodorantes pour l'air
FR2307909A1 (fr) Compositions pour le traitement des etoffes
FR2306710A1 (fr) Composition pour le traitement du colon
BE811068A (fr) Composition pour le traitement des cheveux
FR2274315A1 (fr) Compositions reodorantes pour l'air
BE851775A (fr) Composition pour le traitement de la chevelure
BE873092A (fr) Composition pour le traitement de l'hypertension
FR2277591A1 (fr) Composition pharmaceutique pour la prevention et le traitement de l'alcoolisme
BE829859A (fr) Procedes et compositions pharmaceutiques pour le traitement de l'hypercholesterolemie
FR2340737A1 (fr) Composition pour le traitement de l'hypercholesterolemie
BE872908A (fr) Compositions pharmaceutiques pour le traitement de l'hypertension
BE858692A (fr) Composition pour le traitement de l'acne
FR2279423A1 (fr) Compositions reodorantes pour l'air

Legal Events

Date Code Title Description
ST Notification of lapse